Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Fate Therapeutics Inc. logo

Fate Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

4.96
 
USD
  
-0.17
  
(-3.31%)
Optionable: Yes  Market Cap: 537 M  90-day average vol: 2,623,374

Previous close: 5.13  Open: 5.13  Bid: 4.9  Ask: 4.97
52 week range    
4.02   
   37.13
Peers   
SRPT / 
BDX / 
PTCT / 
RNA / 
Last updated: Wednesday 31st May 2023
35
MarketXLS Rank
40
Value
30
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BDX

0.012972 B37269.27

NBIX

8 B17.481.02

PTCT

3 B-6.243.17

RNA

1 B-7.116.82

SRPT

6 B-11.775.95
Financials

FATE Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Total revenues97100002 M4 M4 M5 M11 M31 M56 M96 M
Cost of sales-571000-496000-687000-1 M-946000-869000-2 M-5 M-11 M-14 M
Gross operating profit97100002 M4 M4 M5 M11 M31 M56 M96 M
Selling Gen & administrative expense7 M8 M10 M10 M12 M16 M24 M34 M57 M84 M
Research & development expense12 M16 M20 M26 M34 M56 M88 M126 M216 M320 M
Operating income-18 M-25 M-28 M-32 M-42 M-67 M-101 M-128 M-217 M-308 M
floaterest income0000000000
floaterest expense0000000000
Other income net-2 M-43200000-11800000-48 M4 M21 M
Pre-tax Income (EBT)-21 M-26 M-30 M-33 M-43 M-67 M-98 M-173 M-212 M-282 M
Income taxes0000000000
Net income from total operations-21 M-26 M-30 M-33 M-43 M-67 M-98 M-173 M-212 M-282 M
Minority floaterest0000000000
Total net income-21 M-26 M-30 M-33 M-43 M-67 M-98 M-173 M-212 M-282 M
Preferred dividendsN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net income available for common-21 M-26 M-30 M-33 M-43 M-67 M-98 M-173 M-212 M-282 M
Depreciation5710004960006870001 M9460008690002 M5 M11 M14 M
Amortization0000000000
Operating income before depreciation (EBITDA)-20 M-25 M-27 M-31 M-41 M-64 M-94 M-170 M-211 M-295 M
Total Income available for floaterest expense (EBIT)0000000000
Basic EPS total-3.54-1.27-1.18-1.05-1.02-1.19-1.44-2.1-2.24-2.91
Diluted EPS total-3.54-1.27-1.18-1.05-1.02-1.19-1.44-2.1-2.24-2.91
Call: 1-877-778-8358
Ankur Mohan MarketXLS
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and starter sheets.
Get started today